Published in J Virol on January 01, 2006
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol (2009) 1.38
Varicella-zoster virus infection of differentiated human neural stem cells. J Virol (2011) 1.34
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J Virol (2008) 1.23
Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol (2014) 1.22
Productive varicella-zoster virus infection of cultured intact human ganglia. J Virol (2007) 1.22
Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response. J Virol (2007) 1.18
Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3. J Virol (2008) 1.06
Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol (2007) 1.04
Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae (2012) 1.04
Simian varicella virus gene expression during acute and latent infection of rhesus macaques. J Neurovirol (2011) 1.03
Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol (2011) 1.01
Varicella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis. J Virol (2012) 0.93
A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol (2015) 0.93
Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol (2013) 0.92
Simian varicella virus induces apoptosis in monkey kidney cells by the intrinsic pathway and involves downregulation of bcl-2 expression. J Virol (2009) 0.91
Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells. J Virol (2006) 0.86
Infected peripheral blood mononuclear cells transmit latent varicella zoster virus infection to the guinea pig enteric nervous system. J Neurovirol (2014) 0.85
Varicella-zoster virus and herpes simplex virus 1 can infect and replicate in the same neurons whether co- or superinfected. J Virol (2014) 0.85
Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84
Does apoptosis play a role in varicella zoster virus latency and reactivation? Viruses (2012) 0.83
The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner. BMC Mol Biol (2007) 0.83
Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection. PLoS Pathog (2013) 0.83
Herpes zoster and the search for an effective vaccine. Clin Exp Immunol (2016) 0.81
Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein. J Virol (2012) 0.81
An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons. PLoS Pathog (2015) 0.81
Brain large artery inflammation associated with HIV and large artery remodeling. AIDS (2016) 0.80
Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk. Int J Cancer (2013) 0.80
Varicella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple Mechanisms. PLoS Pathog (2015) 0.80
Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63. Hybridoma (Larchmt) (2008) 0.79
Inhibition of Bim enhances replication of varicella-zoster virus and delays plaque formation in virus-infected cells. J Virol (2013) 0.79
Simian varicella virus open reading frame 63/70 expression is required for efficient virus replication in culture. J Neurovirol (2011) 0.78
Cellular transcriptome analysis reveals differential expression of pro- and antiapoptosis genes by varicella-zoster virus-infected neurons and fibroblasts. J Virol (2014) 0.77
Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons. Neurobiol Dis (2006) 0.76
Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology. J Neurovirol (2016) 0.75
Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. PLoS Pathog (2015) 0.75
The suppression of apoptosis by α-herpesvirus. Cell Death Dis (2017) 0.75
Probing the nuclear import signal and nuclear transport molecular determinants of PRV ICP22. Cell Biosci (2016) 0.75
Adenovirus death protein (ADP) is required for lytic infection of human lymphocytes. J Virol (2013) 0.75
Acute Simian Varicella Virus Infection Causes Robust and Sustained Changes in Gene Expression in the Sensory Ganglia. J Virol (2016) 0.75
RNA from an immediate early region of the type 1 herpes simplex virus genome is present in the trigeminal ganglia of latently infected mice. Proc Natl Acad Sci U S A (1987) 4.98
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A (1988) 3.49
Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J Virol (1977) 3.32
The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc Natl Acad Sci U S A (1997) 2.98
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A (1998) 2.65
Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol (1995) 2.58
Postherpetic neuralgia. J R Coll Gen Pract (1975) 2.57
Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A (1993) 2.55
Varicella-zoster virus RNA in human trigeminal ganglia. Lancet (1983) 2.39
Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34
Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J Virol (2000) 2.25
The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc Natl Acad Sci U S A (1996) 2.23
The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells. J Virol (1999) 2.06
Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A (2005) 1.89
Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J Virol (2002) 1.67
Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol (1999) 1.64
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology (2001) 1.45
Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol (2003) 1.34
Bcl-2 blocks a caspase-dependent pathway of apoptosis activated by herpes simplex virus 1 infection in HEp-2 cells. J Virol (2000) 1.32
Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain (1991) 1.30
HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol (2001) 1.26
The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1. J Virol (2003) 1.25
Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release. J Virol (1999) 1.22
The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J Virol (2004) 1.22
Herpes simplex virus 1 ICP22 regulates the accumulation of a shorter mRNA and of a truncated US3 protein kinase that exhibits altered functions. J Virol (2005) 1.19
The latency-related gene of bovine herpesvirus 1 inhibits programmed cell death. J Virol (1999) 1.18
Analysis of bovine herpesvirus 1 transcripts during a primary infection of trigeminal ganglia of cattle. J Virol (1997) 1.13
Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci U S A (2004) 1.06
Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for replication in vitro are also critical for efficient establishment of latency. J Virol (2005) 1.05
The latency-related gene encoded by bovine herpesvirus 1 can suppress caspase 3 and caspase 9 cleavage during productive infection. J Neurovirol (2004) 0.97
Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med (2002) 6.23
Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol (2002) 4.63
Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity (2003) 4.49
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 4.23
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood (2003) 3.40
Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol (2006) 2.97
Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One (2008) 2.83
Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science (2008) 2.73
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med (2002) 2.73
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol (2006) 2.67
Primary vaccine failure after 1 dose of varicella vaccine in healthy children. J Infect Dis (2008) 2.37
Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol (2005) 2.31
Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A (2007) 2.13
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc Natl Acad Sci U S A (2010) 2.07
Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain. J Virol (2002) 1.93
Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A (2005) 1.89
Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med (2004) 1.85
Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia. J Virol (2003) 1.80
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol (2007) 1.76
Transport and egress of herpes simplex virus in neurons. Rev Med Virol (2008) 1.72
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol (2005) 1.71
Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J Biol Chem (2004) 1.62
A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 1.57
In rat dorsal root ganglion neurons, herpes simplex virus type 1 tegument forms in the cytoplasm of the cell body. J Virol (2002) 1.56
T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest (2004) 1.56
Retracted Sensory neurons regulate the effector functions of CD8+ T cells in controlling HSV-1 latency ex vivo. Immunity (2005) 1.55
Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons. J Virol (2006) 1.54
Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J Immunol (2005) 1.53
Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. J Virol (2002) 1.53
The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages. Rev Med Virol (2003) 1.50
Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol (2009) 1.49
Identification of structural protein-protein interactions of herpes simplex virus type 1. Virology (2008) 1.49
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol (2005) 1.48
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
Maternal herpes simplex virus antibody avidity and risk of neonatal herpes. Am J Obstet Gynecol (2006) 1.46
Tolerability of treatments for postherpetic neuralgia. Drug Saf (2004) 1.45
Pathogenesis of macrophage tropic HIV-1. Curr HIV Res (2005) 1.43
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS. Retrovirology (2007) 1.41
Functional roles of the tegument proteins of herpes simplex virus type 1. Virus Res (2009) 1.38
The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol (2009) 1.38
The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology (2002) 1.37
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis (2010) 1.36
Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. J Virol (2003) 1.33
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Blood (2011) 1.33
The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J Leukoc Biol (2003) 1.32
A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J Virol (2011) 1.30
Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J Virol (2002) 1.29
Varicella in the fetus and newborn. Semin Fetal Neonatal Med (2008) 1.29
Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Pediatr Infect Dis J (2007) 1.28
Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses. Virol J (2007) 1.28
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res (2005) 1.26
Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. J Virol (2003) 1.25
HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol (2006) 1.24
Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol (2008) 1.24
Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol (2003) 1.23
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res (2010) 1.23
Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. J Virol (2008) 1.23
Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood (2006) 1.22
High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). J Immunol (2009) 1.22
Productive varicella-zoster virus infection of cultured intact human ganglia. J Virol (2007) 1.22
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood (2012) 1.21
Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol (2012) 1.21
Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis (2004) 1.20
Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine (2003) 1.20
Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses. J Infect Dis (2003) 1.19
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. J Infect Dis (2006) 1.19
T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J Virol (2005) 1.19
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology (2007) 1.17
Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. J Virol (2004) 1.17
Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc Natl Acad Sci U S A (2011) 1.16
Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells. J Virol (2004) 1.16
Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase. J Virol (2006) 1.15
Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. J Virol (2008) 1.15
Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog (2011) 1.14
Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. J Virol (2004) 1.14
Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol (2008) 1.13